Please assess the completion status of the following clinical trial:

Trial Title: Prognosis and Therapeutic Biomarkers for Glioblastoma Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 22 years old~* Control Group (only patients evaluated for neurological disorders whose evaluation require a lumbar puncture)~* Non-Control Group - Diagnosed with GBM (Glioblastoma)~Exclusion Criteria:~* Pregnancy~* Infectious Disease to include cold, flu, HIV, etc.~* Blood Disorder (example:low platelets, anemia, thrombosis)~* Vascular Malformations

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: None): None
- Optune Only (Type: None): None
- Optune and TMZ (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).